Roivant Sciences
Developing transformative medicines faster by building technologies and developing talent in creative ways. Learn more
Launch date
Employees
Market cap
AUD13.8b
Enterprise valuation
AUD5.7b (Public information from Sep 2024)
Share price
$12 ROIV
Company register number CHE-289.087.624
New York City New York (HQ), Basel Canton of Basel-Stadt (founding location)
No columns specified